期刊文献+

逍遥归脾汤联合米氮平治疗恶劣心境40例 被引量:1

Clinical Efficacy of Xiaoyao Guipi Decoction Combined with Mirtazapine in Treatment of Dysthymic Disorder:A Report of 40 Cases
下载PDF
导出
摘要 目的观察中西医结合疗法治疗恶劣心境的临床疗效。方法将80例恶劣心境(肝郁脾虚证)患者分为治疗组(逍遥归脾汤联合米氮平治疗)和对照组(单用米氮平治疗),每组40例。治疗前及治疗第4周和第8周末,分别观察两组抑郁自评量表(self-rating depression scale,SDS)和汉密尔顿抑郁量表(Hamilton depression scale,HAMD)评分;治疗第8周末,观察并比较两组中医症状疗效和西医临床疗效。结果治疗第4周和第8周末,两组SDS和HAMD评分均较治疗前显著降低(P<0.01);治疗第8周末,治疗组SDS和HAMD评分下降值显著大于对照组(P<0.05,或P<0.01)。治疗组在中医症状(包括精神抑郁、胸胁作胀、胸闷心悸、脘痞纳呆、善太息、月经不调、脉弦细)总有效率及西医临床总有效率方面显著优于对照组(P<0.05,或P<0.01)。结论逍遥归脾汤联合米氮平治疗恶劣心境(肝郁脾虚证)的疗效优于单用米氮平。 Objective To observe the clinical efficacy of integrated traditional Chinese and Western medicine therapy for dysthymic disorder. Methods Eighty patients with dysthymic disorder (syndrome of stagnation of liver qi and spleen deficiency) were divided into treatment group (n=40) and control group (n= 40). The treatment group received Xiaoyao Guipi Decoction combined with mirtazapine, while the control group received mirtazapine alone. Before and at the ends of weeks 4 and 8 of treatment, Self-Rating De- pression Scale (SDS) and Hamilton Depression Scale (HAMD) scores were determined. At the end of week 8, the treatment outcomes were evaluated and compared in terms of improvements in traditional Chinese medicine (TCM) and Western medicine (WM) symptoms. Results At the ends of weeks 4 and 8, both groups showed significant dedreases in SDS and HAMD scores (P〈0.01). At the end of week 8, the treatment group had significantly higher decreases in SDS and HAMD scores than the control group (P〈 0.05 or P〈0.01). Compared with the control group, the treatment group had significantly higher overall response rates in terms of TCM symptoms (mental depression, chest distress, chest discomfort and palpitation, epigastric oppression and poor appetite, susceptible sigh, irregular menstruation, and fine and string-like pulse) and WM symptoms (P〈0.05 or P〈0.01). Conclusion Xiaoyao Guipi Decoction combined with mirtazapine has better clinical efficacy than mirtazapine alone in the treatment of dysthymic dis order (syndrome of stagnation of liver qi and spleen deficiency).
作者 王军峰
出处 《安徽中医药大学学报》 CAS 2014年第4期33-35,共3页 Journal of Anhui University of Chinese Medicine
关键词 逍遥归脾汤 米氮平 恶劣心境 抑郁自评量表 汉密尔顿抑郁量表 Xiaoyao Guipi Decoction mirtazapine dysthymic disorder Self-Rating Depression Scale Hamilton Depression Scale
  • 相关文献

参考文献8

  • 1张明廉,袁国桢,徐文炜,姚建军,储兴,钱永潮,黄寅平,季庆,张凤娟,周德祥,包召华.无锡市神经症流行病学调查[J].临床精神医学杂志,2005,15(2):78-79. 被引量:17
  • 2国家中医药管理局编..中医病证诊断疗效标准[M].南京:南京大学出版社,1994:218.
  • 3中华医学会精神科分会.中国精神障碍分类及诊断标准[M].3版.济南:山东科学技术出版社,2001:31-168. 被引量:8
  • 4侯沂,舒良.现代精神病诊疗手册[M].北京:北京医科大学出版社,1995:166-167,243-244. 被引量:3
  • 5张明园主编..精神科评定量表手册[M].长沙:湖南科学技术出版社,1998:252.
  • 6盖海山.王琦临床方药应用十讲[M].北京:中国中医药出版社,2007:85. 被引量:3
  • 7黄承吴.折肱漫录[M].上海:上海中医药大学出版社,2012:34. 被引量:1
  • 8杨明辉,邓晓舫,黄健.米氮平与氟西汀治疗抑郁症的对照研究[J].临床精神医学杂志,2004,14(5):288-289. 被引量:15

二级参考文献8

  • 1张明园 见:夏镇夷 主编.神经症[M].见:夏镇夷,主编.实用精神医学[C].上海:上海科学技术出版社,1990.179-185. 被引量:1
  • 2刘协和 夏镇夷 主编.神经症[M].夏镇夷,主编.临床精神医学.第2版[C].长沙:湖南科学技术出版社,1994.451-455. 被引量:1
  • 3Tsung-yi Lin.Normal and abnormal behavior in Chinese culture[M].Holland:Dordrecht,1981.273. 被引量:1
  • 4李心天.医学心理学[M].北京:人民卫生出版社,1997.143-162. 被引量:29
  • 5De Boer T,Nefkens F,Van Helvoirt A.The α2-adrenoceptor antagonist org 3770 enhances serotonin transmission in vivo[J].Eur J Pharmacology,1994,253:5-6. 被引量:1
  • 6Haddjeri N,Blier P,De Montigny C.Noradrenergic Modulation of central serotonergic neurotransmission:acute and long-term actions of mirtazapine[J].lnt Clin Psychopharmacol,1995,10(Suppl 4):11-17. 被引量:1
  • 7Wheatley DP,van Moffaert M,Timmerman L,et al.Mirtazapine:Efficacy and tolerability in comparison with tluoxetine in patients with moderate to severe major depressive disorder[J].J Clin Psychiatry,1998,59:306-313. 被引量:1
  • 8陈昌惠,沈渔笛,张维熙,李淑然,黄悦勤,王金荣,王德平,涂建,宁佐喜,付力牧,纪丽萍,刘志广,吴化民,罗开林,翟书涛,严和,孟国荣.中国七个地区精神分裂症流行病学调查[J].中华精神科杂志,1998,31(2):72-74. 被引量:173

共引文献41

同被引文献28

引证文献1

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部